Serpina3ntm1.2Lbrl
Targeted Allele Detail
|
|
| Symbol: |
Serpina3ntm1.2Lbrl |
| Name: |
serine (or cysteine) peptidase inhibitor, clade A, member 3N; targeted mutation 1.2, |
| MGI ID: |
MGI:5635504 |
| Gene: |
Serpina3n Location: Chr12:104372988-104380588 bp, + strand Genetic Position: Chr12, 54.17 cM, cytoband F1
|
| Alliance: |
Serpina3ntm1.2Lbrl page
|
|
| Germline Transmission: |
Earliest citation of germline transmission:
J:220590
|
| Parent Cell Line: |
W4 (ES Cell)
|
| Strain of Origin: |
129S6/SvEvTac
|
|
| Allele Type: |
|
Targeted (Null/knockout) |
| Mutations: |
|
Insertion, Intragenic deletion
|
| |
|
Mutation details: A targeting vector was designed to insert a loxP site upstream of exon 2, and a frt-flanked neomycin resistance (neo) cassette followed by a second loxP site downstream of exon 2. Flp-mediated recombination removed the selection cassette. Cre-mediated recombination removed exon 2.
(J:220590)
|
|
|
View phenotypes and curated references for all genotypes (concatenated display).
|
| Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
| Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 0 lines available
|
| Carrying any Serpina3n Mutation: |
33 strains or lines available
|
|
| Original: |
J:220590 Vicuna L, et al., The serine protease inhibitor SerpinA3N attenuates neuropathic pain by inhibiting T cell-derived leukocyte elastase. Nat Med. 2015 May;21(5):518-23 |
| All: |
1 reference(s) |
|